Genedrive PLC | Cash Flow

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,519.00
2,295.00
4,040.00
5,426.00
7,292.00
7,375
Depreciation, Depletion & Amortization
254.00
328.00
385.00
1,174.00
1,072.00
1,079
Other Funds
269.00
855.00
1,311.00
410.00
3,089.00
4,064
Funds from Operations
996.00
1,112.00
2,344.00
3,842.00
3,131.00
2,232
Changes in Working Capital
384.00
34.00
1,158.00
44.00
1,308.00
302
Net Operating Cash Flow
612.00
1,146.00
3,502.00
3,798.00
1,823.00
2,534
Capital Expenditures
1,727.00
1,482.00
758.00
164.00
70.00
Net Investing Cash Flow
1,727.00
1,482.00
758.00
164.00
70.00
Issuance/Reduction of Debt, Net
-
-
4,600.00
-
-
Net Financing Cash Flow
4,177.00
344.00
4,658.00
44.00
6,023.00
Net Change in Cash
1,838.00
2,284.00
690.00
3,814.00
4,015.00
Free Cash Flow
2,339.00
2,628.00
3,710.00
3,946.00
1,893.00
Change in Capital Stock
4,177.00
344.00
58.00
44.00
6,023.00
Exchange Rate Effect
-
-
292.00
192.00
115.00

About Genedrive

View Profile
Address
48 Grafton Street
Manchester Greater Manchester M13 9XX
United Kingdom
Employees -
Website http://epistem.co.uk
Updated 07/08/2019
Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. It operates through the following segments: Preclinical Research Services, Pharmacogenomics Services, and Diagnostics. The Preclinical Research Services segment provides pre-clinical testing services.